Correlation Between Corvus Pharmaceuticals and Werewolf Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Corvus Pharmaceuticals and Werewolf Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corvus Pharmaceuticals and Werewolf Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corvus Pharmaceuticals and Werewolf Therapeutics, you can compare the effects of market volatilities on Corvus Pharmaceuticals and Werewolf Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corvus Pharmaceuticals with a short position of Werewolf Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corvus Pharmaceuticals and Werewolf Therapeutics.

Diversification Opportunities for Corvus Pharmaceuticals and Werewolf Therapeutics

0.18
  Correlation Coefficient

Average diversification

The 3 months correlation between Corvus and Werewolf is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Corvus Pharmaceuticals and Werewolf Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Werewolf Therapeutics and Corvus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corvus Pharmaceuticals are associated (or correlated) with Werewolf Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Werewolf Therapeutics has no effect on the direction of Corvus Pharmaceuticals i.e., Corvus Pharmaceuticals and Werewolf Therapeutics go up and down completely randomly.

Pair Corralation between Corvus Pharmaceuticals and Werewolf Therapeutics

Given the investment horizon of 90 days Corvus Pharmaceuticals is expected to generate 0.84 times more return on investment than Werewolf Therapeutics. However, Corvus Pharmaceuticals is 1.2 times less risky than Werewolf Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Werewolf Therapeutics is currently generating about 0.03 per unit of risk. If you would invest  77.00  in Corvus Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of  832.00  from holding Corvus Pharmaceuticals or generate 1080.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Corvus Pharmaceuticals  vs.  Werewolf Therapeutics

 Performance 
       Timeline  
Corvus Pharmaceuticals 

Risk-Adjusted Performance

22 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Corvus Pharmaceuticals are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Corvus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
Werewolf Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Werewolf Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite quite unsteady basic indicators, Werewolf Therapeutics disclosed solid returns over the last few months and may actually be approaching a breakup point.

Corvus Pharmaceuticals and Werewolf Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Corvus Pharmaceuticals and Werewolf Therapeutics

The main advantage of trading using opposite Corvus Pharmaceuticals and Werewolf Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corvus Pharmaceuticals position performs unexpectedly, Werewolf Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Werewolf Therapeutics will offset losses from the drop in Werewolf Therapeutics' long position.
The idea behind Corvus Pharmaceuticals and Werewolf Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
CEOs Directory
Screen CEOs from public companies around the world
Insider Screener
Find insiders across different sectors to evaluate their impact on performance